George Van Buren, II, M.D., FACS
Picture
George Van Buren, II, M.D., FACS
Professor of Surgery
Phone
Phone
Positions
- Professor of Surgery
-
Division of Surgical Oncology
Baylor College of Medicine
- Faculty Senator
-
Baylor College of Medicine
- Medical Director
-
Surgery
Surgical Oncology
Baylor College of Medicine
Houston, Texas United States
- Member
-
Surgery
Surgical Oncology
Elkins Pancreas Center
Houston, Texas United States
Addresses
- Dan L Duncan Comprehensive Cancer Center (Clinic)
-
O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX 77054
United States
Phone: (832) 957-6500
Interactive Map
Education
- Clinical Fellowship at University of Pittsburgh Medical Center
- 06/2012 - Pittsburgh, Pennsylvania United States
- Surgical Oncology Fellowship, Pancreatic Surgery Fellowship
- Fellowship at The University of Texas MD Anderson Cancer Center
- 06/2007 - Houston, Texas United States
- Surgical Oncology, NIH T32 Research Fellowship
- Residency at The University of Texas Health Science Center
- 06/2010 - Houston, Texas United States
- General Surgery Residency
- MD from The University of Texas Health Science Center
- 06/2003 - Houston, Texas United States
- BA from The University of Texas At Austin
- 05/1999 - Austin, Texas United States
- Biology
- Graduate Certificate at Rice University, Jones Graduate School of Business
- Houston
- Healthcare Management
Certifications
- Board Certified
- American Board of Surgery
- Certificate in Complex Surgical Oncology
- Society of Surgical Oncology
- Medical License
- #M5961
- Texas Medical Board
- Fellow of the American College of Surgeons
- (10/26/2014)
- American College of Surgeons
Honors & Awards
- Norton Rose Fulbright Faculty Excellence Award for Teaching & Evaluation
- Baylor College of Medicine
- Early Career Faculty Award for Excellence in Patient Care
- Baylor College of Medicine
- Barry Stephen Smith Memorial Pancreatic Cancer Research Award
- Dan L Duncan Comprehensive Cancer Center
- Star Faculty Award for Excellence in Patient Care
- Baylor College of Medicine (05/2020)
- Chief Resident Faculty Teaching Award
- 2017, 2019
- Baylor College of Medicine
- Houstonia Magazine, Top Doctors
- 2015, 2016, 2017, 2018, 2019, 2020
- Houstonia Magazine
- Texas Monthly, Texas Rising Stars
- 2017, 2017, 2018
- Texas Monthly Magazine
- Faculty Senate Member
- 2015- 2021
- Baylor College of Medicine
- Faculty Full Tenure
- 2018
- Baylor College of Medicine
- Alpha Omega Alpha
- 2004
- The University of Texas Health Science Center at Houston
- Texas Monthly, Top Doctor
- 2020
- Texas Monthly Magazine
- Gene Guinn MD Outstanding Teaching Faculty Award
- 2020
- Baylor College of Medicine
- 2020 Top Doctor: General Surgery
- Houstonia Magazine
Professional Interests
- Pancreas cancer surgery
- Pancreaticoduodenectomy (Whipple Procedure)
- Surgical oncology
- Stomach cancer
- Colon cancer
- Sentinel Lymph node biopsy
- Distal Pancreatectomy
- HIPEC
- Pancreatic neuroendocrine tumors
- Pancreatic adenocarcinoma
- Minimally invasive surgery
- Laparoscopic colectomy, gastrectomy and adrenalectomy
- Pancreas Cancer
- Gastric Adenocarcinoma
- Neuroendocrine Tumors
- Gastrointestinal Cancer
- Gastrointestinal Stromal Tumors (GIST)
- Gastrectomy
Professional Statement
George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.
During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.
Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine.
Currently at the Elkins Pancreas Center we are enrolling patients in neoadjuvant, adjuvant, and metastatic clinical trials for pancreatic cancer. In addition, we do have ongoing surgical clinical trials to determine how to optimize acute surgical outcomes.
Websites
In the News:
YouTube Videos:
Videos
Dr. George Van Buren describes his background and specialized training to become a pancreatic surgeon.
Selected Publications
- Van Buren G, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM "Effect of molecular therapeutics on liver regeneration in a murine model.." J. Clin. Oncol.. 2008 Apr 10;26(11):1836-42. Pubmed PMID: 18398149
- Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G, Samuel S, Kim MP, Lim SJ, Ellis LM "Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.." Cancer Res.. 2009 Mar 1;69(5):1951-7. Pubmed PMID: 19244128
- Dallas NA, Fan F, Gray MJ, Van Buren G, Lim SJ, Xia L, Ellis LM "Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells.." Cancer Metastasis Rev.. 2007 Dec;26(41337):433-41. Pubmed PMID: 17786539
- Fan F, Gray MJ, Dallas NA, Yang AD, Van Buren G, Camp ER, Ellis LM "Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.." Mol. Cancer Ther.. 2008 Sep;7(9):3064-70. Pubmed PMID: 18790786
- Van Buren G, Fisher WE "A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage.." Ann Surg. 2013 26; Pubmed PMID: 24374513
- Ross A, Mohammed S, Vanburen G, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE. "An assessment of the necessity of transfusion during pancreatoduodenectomy.." Surgery. 2013 Sep; Pubmed PMID: 23972656
- Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM "Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.." Clin. Cancer Res.. 2006 Jul 15;12(14):4147-53. Pubmed PMID: 16857785
- Dallas NA, Gray MJ, Xia L, Fan F, van Buren G, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM "Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.." Clin. Cancer Res.. 2008 Dec 15;14(24):8052-60. Pubmed PMID: 19088020
- Van Buren G 2nd, Ramanathan RK, Krasinskas AM, Smith RP, Abood GJ, Bahary N, Lembersky BC, Shuai Y, Potter DM, Bartlett DL, Zureikat AH, Zeh HJ, James Moser A "Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma." Ann Surg Oncol. 2013 20; Pubmed PMID: 23904005
- Mohammed S, Van Buren II G, Fisher WE. "Pancreatic cancer: Advances in treatment.." World J Gastroenterol. 2014 Jul 28; Pubmed PMID: 25071330
- Van Buren G, Teichgraeber DC, Ghorbani RP, Souchon EA "Sequential stenotic strictures of the small bowel leading to obstruction.." World J. Gastroenterol.. 2007 Oct 28;13(40):5391-3. Pubmed PMID: 17879413
- Mohammed S, Evans C, Vanburen G, Hodges SE, Silberfein E, Artinyan A, Mo Q, Issazadeh M, McElhany AL, Fisher WE. "Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy." HPB. 2013 Aug 29; Pubmed PMID: 23992045
- Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM "Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.." J. Natl. Cancer Inst.. 2008 Jan 16;100(2):109-20. Pubmed PMID: 18182619
- Gray MJ, Dallas NA, Van Buren G, Xia L, Yang AD, Somcio RJ, Gaur P, Mangala LS, Vivas-Mejia PE, Fan F, Sanguino AM, Gallick GE, Lopez-Berestein G, Sood AK, Ellis LM "Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.." Oncogene. 2008 Dec 4;27(57):7192-200. Pubmed PMID: 18806828
- Van Buren G, Camp ER, Yang AD, Gray MJ, Fan F, Somcio R, Ellis LM "The role of nitric oxide in mediating tumour blood flow.." Expert Opin. Ther. Targets. 2006 Oct;10(5):689-701. Pubmed PMID: 16981826
- Van Buren G, Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Fan F, Camp ER, Yao JC, Ellis LM "The development and characterization of a human midgut carcinoid cell line.." Clin. Cancer Res.. 2007 Aug 15;13(16):4704-12. Pubmed PMID: 17699847
- Van Buren G, Gray MJ, Dallas NA, Xia L, Lim SJ, Fan F, Mazar AP, Ellis LM "Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.." Cancer. 2009 Jul 15;115(14):3360-8. Pubmed PMID: 19484792
- Van Buren G 2nd, et al "A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage." 2017; Pubmed PMID: 28692468
- Shah KP, Baugh KA, Brubaker LS, Van Buren G 2nd, Villafane-Ferriol N, McElhany AL, Mohamed S, Silberfein EJ, Hsu C, Massarweh NN, Tran Cao HS, Mendez-Reyes JE, Fisher WE "Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms." 2019; Pubmed PMID: 31740011
- Gilliland TM, Villafane-Ferriol N, Shah KP, Shah RM, Tran Cao HS, Massarweh NN, Silberfein EJ, Choi EA, Hsu C, McElhany AL, Barakat O, Fisher W, Van Buren G "Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients." 2017; Pubmed PMID: 28272344
- Khawja S, Mohammed S, Silberfein E, Musher B, Fisher WE, Van Buren G 2nd "Pancreatic Cancer Disparities in African Americans." 2015; Pubmed PMID: 25872128
- Baugh KA, Villafane N, Farinas C, Dhingra S, Silberfein EJ, Massarweh NN, Cao HT, Fisher WE, Van Buren G 2nd "Pancreatic Incidentalomas: A Management Algorithm for Identifying Ectopic Spleens." 2018; Pubmed PMID: 30694749
Projects
- Microbiome in Pancreatic Disease
- Baylor College of Medicine
- Elkins Pancreas Center
- Mitigation Strategies for Post Operative Pancreatic Fistulas (POPF)
- Baylor College of Medicine
Memberships
- Texas Medical Association
- American College of Surgeons
- Fellow
- Association for Academic Surgery
- Harris County Medical Society
- Society for Surgical Oncology
- American Hepato-Pancreato-Biliary Association
- The Pancreas Club
Funding
- U01: Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CSCPDPC). Altered Microbiome in Pancreatitis, Diabetes and Pancreatic Cancer - #1U01DK108326-01 (06/01/2015 - 06/01/2020) Grant funding from National Institute of Diabetes and Digestive and Kidney Diseases
- R21 Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition Building a Pancreas Surgery Consortium via Randomized Controlled Trial of Drain Placement (06/01/2015 - 06/01/2017) Grant funding from NIH
- Pancreatic Cancer Immunotherapy Co-clinical Trial using Pre-clinical Mouse Model (06/01/2017 - 06/01/2019) Grant funding from Roderick D. MacDonald Research Fund at Baylor St. Luke’s Medical Center
- Curing Pancreatic Cancer with NK Cell Immunotherapy (06/01/2018 - 06/01/2019) Grant funding from Barry Stephen Smith Memorial Pancreatic Cancer Research Award
- R33 Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation (06/01/2019 - 06/01/2024) Grant funding from NCI
Skills
- Pancreatic Surgery
- Surgical Oncology
- Gastric Cancer
- Pancreatic Diseases
Languages
Spanish
Log In to edit your profile
